Lubiprostone For Constipation: Dosage, Safety, What To Know
Effective treatment for chronic constipation: Learn about Amitiza's uses, dosage, side effects, and practical advice for better bowel health.
Lubiprostone, marketed as Amitiza, is a prescription medication designed to treat chronic constipation by increasing fluid secretion in the intestines, softening stools, and promoting bowel movements.
About lubiprostone
Lubiprostone is a selective chloride channel activator that targets ClC-2 channels in the apical membrane of the human intestine. This action increases intestinal fluid secretion without altering sodium or potassium concentrations in the serum, thereby enhancing motility and facilitating stool passage. It is particularly useful for chronic idiopathic constipation (CIC), defined as constipation lasting at least 12 weeks without a known cause, irritable bowel syndrome with constipation (IBS-C) in women aged 18 and older, and opioid-induced constipation (OIC) in adults with chronic non-cancer pain.
Unlike traditional laxatives that stimulate peristalsis or bulk stools, lubiprostone works locally in the gut with minimal systemic absorption. Peak plasma levels of its active metabolite (M3) occur around 1.1 hours post-dose, but lubiprostone itself remains below quantifiable levels (<10 pg/mL), reducing systemic side effects. Clinical trials have shown it increases spontaneous bowel movements (SBMs) within 24 hours in 56-63% of patients versus 32-37% on placebo, with improvements in stool consistency, straining, and bloating.
The U.S. Food and Drug Administration (FDA) approved Amitiza for CIC in adults on January 31, 2006, later expanding indications to IBS-C and OIC. It is not approved for children, though studies explore pediatric functional constipation.
Before taking lubiprostone
Consult your doctor before starting lubiprostone if you have severe diarrhea, bowel obstruction symptoms (e.g., nausea, vomiting, severe abdominal pain), or known or suspected mechanical GI obstruction, as it could worsen these conditions. It is contraindicated in patients with known or suspected bowel obstruction.
Pregnant women should avoid it unless benefits outweigh risks; it is Pregnancy Category C. Animal studies showed no teratogenicity, but human data are limited. Effective contraception is advised during treatment. Use caution in hepatic impairment (Child-Pugh Class B or C); reduce dose to 16 mcg twice daily for severe cases. No adjustment needed for mild hepatic or renal impairment.
Inform your doctor of all medications, as lubiprostone may interact with CYP3A4 inducers/inhibitors or P-glycoprotein substrates, though its low bioavailability limits most interactions. It is not recommended for those under 18.
How to take lubiprostone
Follow your doctor’s instructions precisely. Standard dosing for chronic idiopathic constipation and opioid-induced constipation in adults is 24 mcg twice daily (one 24 mcg capsule after breakfast and supper). For IBS-C in women 18+, it is 8 mcg twice daily. Swallow capsules whole with water, always with food to reduce nausea.
Treatment duration is typically 2-4 weeks initially, but may extend for chronic use under medical supervision. Do not exceed prescribed dose. If a dose is missed, take the next one with food; do not double up.
| Indication | Dose | Frequency | Notes |
|---|---|---|---|
| Chronic Idiopathic Constipation (Adults) | 24 mcg | Twice daily | With food |
| Opioid-Induced Constipation (Adults) | 24 mcg | Twice daily | With food; chronic non-cancer pain |
| IBS-C (Women ≥18 years) | 8 mcg | Twice daily | With food |
| Hepatic Impairment (Severe) | 16 mcg (CIC/OIC) 8 mcg (IBS-C) | Twice daily | Monitor closely |
Getting the most from your treatment
To optimize results, combine lubiprostone with lifestyle changes:
- Diet: Increase fiber gradually (20-30g/day from fruits, vegetables, whole grains) and stay hydrated (8-10 glasses water daily).
- Exercise: Aim for 30 minutes moderate activity most days to stimulate bowel motility.
- Habits: Establish a regular toilet routine; do not ignore urges. Elevate feet on a stool during bowel movements to mimic squatting.
- Monitoring: Track bowel movements, consistency (Bristol Stool Scale), and symptoms. Report lack of improvement after 2 weeks or worsening symptoms.
- Continue treatment as prescribed; abrupt stopping may reduce efficacy. For OIC, it can be used with continued opioids.
Clinical studies confirm lubiprostone’s superiority over placebo and equivalence to senna in some opioid settings, with faster SBM onset.
Can lubiprostone cause problems?
The most common side effect is nausea (up to 29% in trials, often mild and dose-related; taking with food mitigates). Other frequent issues include:
- Diarrhea (12%)
- Headache (13%)
- Abdominal pain (8%)
- Dizziness, flatulence, loose stools.
Serious risks (rare):
- Dyspnea: Acute onset 30-60 min post-dose (1-2%), resolves quickly but recurs; discontinue if persistent.
- Bowel obstruction: Avoid in at-risk patients.
- Fecal incontinence, urgency, cramps (more vs. placebo).
Seek immediate help for severe allergic reactions (rash, swelling, breathing difficulty), severe diarrhea, or black/tarry stools. Long-term use appears safe, with no new signals in extended trials. Nausea often diminishes after first week.
How to store lubiprostone
Store Amitiza capsules at room temperature (20-25°C/68-77°F), in original packaging protected from light and moisture. Do not use past expiration date. Keep out of reach of children.
Important information about all medicines
Never share prescription medicines. Inform doctors/pharmacists of all drugs/supplements. Report side effects via FDA MedWatch or local systems. Driving/operating machinery is generally safe unless dizziness occurs.
For constipation persisting despite treatment, investigate underlying causes (e.g., hypothyroidism, medications).
Frequently Asked Questions (FAQs)
Who should not take lubiprostone?
Avoid if you have bowel obstruction, severe diarrhea, or are pregnant unless advised. Not for children under 18.
How quickly does Amitiza work?
Many experience SBMs within 24 hours; full benefits in 1-2 weeks.
Can I take Amitiza on an empty stomach?
No, always with food to minimize nausea.
Is lubiprostone safe long-term?
Yes, for chronic use under supervision; monitor for side effects.
What if I miss a dose?
Take next dose with food; do not double.
References
- Lubiprostone (Amitiza) for Chronic Idiopathic Constipation — American Academy of Family Physicians (AAFP). 2006-10-15. https://www.aafp.org/pubs/afp/issues/2006/1015/p1380.html
- Amitiza (lubiprostone) Capsules Label — U.S. Food and Drug Administration (FDA). 2012-09-14. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021908s010lbl.pdf
- Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation — ClinicalTrials.gov (NCT00662363). N/A. https://clinicaltrials.gov/study/NCT00662363
- Lubiprostone for constipation — Patient.info. N/A. https://patient.info/medicine/lubiprostone-for-constipation-amitiza
- Lubiprostone (oral route) — Mayo Clinic. N/A. https://www.mayoclinic.org/drugs-supplements/lubiprostone-oral-route/description/drg-20069057
- Lubiprostone: Uses, Interactions, Mechanism of Action — DrugBank. N/A. https://go.drugbank.com/drugs/DB01046
- Lubiprostone: a novel treatment for chronic constipation — National Institutes of Health (PMC). 2008-10. https://pmc.ncbi.nlm.nih.gov/articles/PMC2546479/
Similar Articles
Read full bio of Sneha Tete
